Retina Synthesis

147 Episoade

1. 18 Month Results of the Derby and Oaks Trials for Treatment of Geographic Atrophy

   Publicat: 04.08.2022
2. A Novel Retinal Sealant

   Publicat: 28.07.2022
3. New Developments in Imaging and Therapy of Sickle Cell Retinopathy

   Publicat: 21.07.2022
4. High Dose (8mg) Aflibercept for Treatment of Neovascular AMD

   Publicat: 07.07.2022
5. New Developments in the Management of Choroidal Melanoma

   Publicat: 30.06.2022
6. A Stem Cell Implant for the Treatment of Geographic Atrophy

   Publicat: 23.06.2022
7. DERBY and OAKS Results

   Publicat: 16.06.2022
8. Artificial Intelligence in the Management of Macular Degeneration

   Publicat: 09.06.2022
9. An Oral Agent for the Treatment of Diabetic Retinopathy

   Publicat: 02.06.2022
10. Home OCT Monitoring of Neovascular AMD Treatment

    Publicat: 26.05.2022
11. Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies

    Publicat: 19.05.2022
12. The Kingfisher Trial of Brolucizumab for DME

    Publicat: 12.05.2022
13. Subretinal Fluid in Neovascular AMD: Friend or Foe?

    Publicat: 05.05.2022
14. Optogenetics

    Publicat: 28.04.2022
15. Inhibition of Plasma Kallikrein in Diabetic Macular Edema

    Publicat: 21.04.2022
16. Neovascular AMD: Unpacking Surgical Disease Management Options

    Publicat: 14.04.2022
17. Ocular Therapeutics Sustained Release TKI Trial

    Publicat: 07.04.2022
18. Gene Therapy of nAMD and Diabetic Retinopathy with Dr. Allen Ho

    Publicat: 31.03.2022
19. Long Term Results of the Port Delivery System

    Publicat: 24.03.2022
20. The Altissimo Study using a TKI for nAMD

    Publicat: 17.03.2022